{"transactions":[{"id":738810,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38437,"kind":"person","name":"Goodwin Charles D. II","position":1,"cik":"0001726988","reported_name":"Goodwin Charles D. II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Option to Buy)","published_at":"2026-06-15T23:00:09.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":213948,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant."}],"balance_after":213948,"derivative":{"exercise_price":4.65,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":213948},"source":{"system":"sec-edgar","filing":"0001493152-26-028770","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000149315226028770/ownership.xml","form_type":"4"}},{"id":1144242,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38437,"kind":"person","name":"Goodwin Charles D. II","position":1,"cik":"0001726988","reported_name":"Goodwin Charles D. II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Option to Buy)","published_at":"2025-05-19T20:31:05.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":193000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant."}],"balance_after":193000,"derivative":{"exercise_price":1.48,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":193000},"source":{"system":"sec-edgar","filing":"0001641172-25-011474","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000164117225011474/ownership.xml","form_type":"4"}},{"id":1301136,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38437,"kind":"person","name":"Goodwin Charles D. II","position":1,"cik":"0001726988","reported_name":"Goodwin Charles D. II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Option to Buy)","published_at":"2025-01-17T21:07:06.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably over a thirty-six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant."}],"balance_after":50000,"derivative":{"exercise_price":1.42,"expiration_date":"2035-01-15","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-25-002763","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000149315225002763/ownership.xml","form_type":"4"}},{"id":1681219,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38437,"kind":"person","name":"Goodwin Charles D. II","position":1,"cik":"0001726988","reported_name":"Goodwin Charles D. II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Option to Buy)","published_at":"2024-01-11T21:05:35.000Z","date":"2024-01-10","kind":"grant","planned":false,"acquired":true,"shares":243000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":2.42,"exercise_date":"2027-01-10","expiration_date":"2034-01-10","underlying":"Common Stock","underlying_shares":243000},"source":{"system":"sec-edgar","filing":"0001493152-24-002060","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000149315224002060/ownership.xml","form_type":"4"}},{"id":1741717,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38437,"kind":"person","name":"Goodwin Charles D. II","position":1,"cik":"0001726988","reported_name":"Goodwin Charles D. II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-11-15T21:12:42.000Z","date":"2023-11-14","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":1.57,"value":78500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at a prices ranging from $1.56 to $1.57. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":90000,"source":{"system":"sec-edgar","filing":"0001493152-23-041501","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000149315223041501/ownership.xml","form_type":"4"}},{"id":2055216,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38437,"kind":"person","name":"Goodwin Charles D. II","position":1,"cik":"0001726988","reported_name":"Goodwin Charles D. II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Option to Buy)","published_at":"2023-01-13T21:16:05.000Z","date":"2023-01-11","kind":"grant","acquired":true,"shares":243000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant."}],"balance_after":243000,"derivative":{"exercise_price":2.5,"exercise_date":"2026-01-11","expiration_date":"2033-01-11","underlying":"Common Stock","underlying_shares":243000},"source":{"system":"sec-edgar","filing":"0000719135-23-000003","document":"wf-form4_167364454886580.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000071913523000003/wf-form4_167364454886580.xml","form_type":"4"}},{"id":2170483,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38437,"kind":"person","name":"Goodwin Charles D. II","position":1,"cik":"0001726988","reported_name":"Goodwin Charles D. II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-31T20:51:38.000Z","date":"2022-08-29","kind":"purchase","acquired":true,"shares":9750,"price":5.97,"value":58207.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $5.90 to $5.99.  The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth.  The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0000719135-22-000084","document":"wf-form4_166197908352652.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/719135/000071913522000084/wf-form4_166197908352652.xml","form_type":"4"}},{"id":2170482,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38437,"kind":"person","name":"Goodwin Charles D. II","position":1,"cik":"0001726988","reported_name":"Goodwin Charles D. II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-31T20:51:38.000Z","date":"2022-08-29","kind":"purchase","acquired":true,"shares":2000,"price":5.93,"value":11860.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $5.92 to $5.93.  The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth.  The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":30250,"source":{"system":"sec-edgar","filing":"0000719135-22-000084","document":"wf-form4_166197908352652.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000071913522000084/wf-form4_166197908352652.xml","form_type":"4"}},{"id":2421859,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38437,"kind":"person","name":"Goodwin Charles D. II","position":1,"cik":"0001726988","reported_name":"Goodwin Charles D. II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Option to Buy)","published_at":"2022-02-01T00:11:08.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":243000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant."}],"balance_after":243000,"derivative":{"exercise_price":10.96,"exercise_date":"2025-01-19","expiration_date":"2032-01-19","underlying":"Common Stock","underlying_shares":243000},"source":{"system":"sec-edgar","filing":"0000719135-22-000008","document":"wf-form4_164367424996384.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000071913522000008/wf-form4_164367424996384.xml","form_type":"4"}},{"id":2873372,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38437,"kind":"person","name":"Goodwin Charles D. II","position":1,"cik":"0001726988","reported_name":"Goodwin Charles D. II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-09T16:35:44.000Z","date":"2021-01-29","kind":"grant","acquired":true,"shares":121500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant."}],"balance_after":121500,"derivative":{"exercise_price":9.29,"exercise_date":"2024-01-29","expiration_date":"2031-01-29","underlying":"Common Stock","underlying_shares":121500},"source":{"system":"sec-edgar","filing":"0000719135-21-000008","document":"wf-form4_161288853061139.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000071913521000008/wf-form4_161288853061139.xml","form_type":"4"}},{"id":3149996,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38437,"kind":"person","name":"Goodwin Charles D. II","position":1,"cik":"0001726988","reported_name":"Goodwin Charles D. II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-05-14T17:27:16.000Z","date":"2020-05-13","kind":"purchase","acquired":true,"shares":28250,"price":3.299,"value":93196.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Average price of shares purchased on the open market on May 13, 2020, ranging from $3.06 to $3.33 per share."}],"balance_after":28250,"source":{"system":"sec-edgar","filing":"0000719135-20-000045","document":"wf-form4_158947721868646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000071913520000045/wf-form4_158947721868646.xml","form_type":"4"}},{"id":3305650,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38437,"kind":"person","name":"Goodwin Charles D. II","position":1,"cik":"0001726988","reported_name":"Goodwin Charles D. II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Option to Buy)","published_at":"2020-01-22T22:17:02.000Z","date":"2020-01-15","kind":"grant","acquired":true,"shares":243000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant."}],"balance_after":243000,"derivative":{"exercise_price":8.18,"exercise_date":"2023-01-15","expiration_date":"2030-01-15","underlying":"Common Stock","underlying_shares":243000},"source":{"system":"sec-edgar","filing":"0000719135-20-000009","document":"wf-form4_157973140374028.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000071913520000009/wf-form4_157973140374028.xml","form_type":"4"}},{"id":3666968,"issuer":{"id":6609,"kind":"organization","name":"Apyx Medical Corp"},"owners":[{"id":38437,"kind":"person","name":"Goodwin Charles D. II","position":1,"cik":"0001726988","reported_name":"Goodwin Charles D. II","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Option to Buy)","published_at":"2019-02-12T00:17:24.000Z","date":"2019-01-09","kind":"grant","acquired":true,"shares":236000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant."}],"balance_after":236000,"derivative":{"exercise_price":7.91,"exercise_date":"2022-01-09","expiration_date":"2029-01-09","underlying":"Common Stock","underlying_shares":236000},"source":{"system":"sec-edgar","filing":"0000719135-19-000014","document":"wf-form4_154993062663073.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/719135/000071913519000014/wf-form4_154993062663073.xml","form_type":"4"}}]}